Home | Publications | Medical Devices place holder
place holder place holder

Medical Devices

Canada Ophthalmic Devices Investment Opportunities

Analysis and Forecasts to 2012

Publication Date   July 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   94
ISBN Number   not applicable
Product Code   GMD1062
Ask a question about this product?

Price £1,005.00

approximately: $1,499 | €1,197

Summary


Canada Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Canada ophthalmic devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ophthalmic devices in Canada

Scope

  • The report provides ophthalmic devices information broken down into detailed categories and segments in Canada.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the ophthalmic devices market in Canada.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 Ophthalmic Devices
    • 3.2 Cataract Surgery
      • 3.2.1 Phacoemulsification Equipment
      • 3.2.2 Intra Ocular Lens
    • 3.3 Vision Care
      • 3.3.1 Ophthalmoscopes
      • 3.3.2 Contact lenses
      • 3.3.3 Lens care
      • 3.3.4 Ophthalmic lens
      • 3.3.5 Rigid Gas Permeable Contact Lenses
    • 3.4 Refractive Surgery
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Conformity Assessment
      • 5.1.3 License Fee
      • 5.1.4 License Application Processing Duration
    • 5.2 Labeling and Packaging
    • 5.3 Post-Market Surveillance
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
    • 7.1 Distribution Structure
  • 8 Canada Medical Equipment Cross Market Comparison
  • 9 Ophthalmic Devices Cross Country Comparison
  • 10 Ophthalmic Devices in Canada
    • 10.1 Ophthalmic Devices Overall Revenues by Category (2000-2012)
    • 10.2 Ophthalmic Devices Overall Volume by Category (2000-2012)
    • 10.3 Ophthalmic Devices Overall Company Share (2006-2007)
  • 11 Vision Care in Canada
    • 11.1 Vision Care Revenues by Segment (2000-2012)
    • 11.2 Vision Care Volume by Segment (2000-2012)
    • 11.3 Vision Care Average Price (2000-2012)
    • 11.4 Vision Care Distribution Share (2006-2007)
    • 11.5 Vision Care Company Share (2006-2007)
  • 12 Cataract Surgery in Canada
    • 12.1 Cataract Surgery Revenues by Segment (2000-2012)
    • 12.2 Cataract Surgery Volume by Segment (2000-2012)
    • 12.3 Cataract Surgery Average Price (2000-2012)
    • 12.4 Cataract Surgery Distribution Share (2006-2007)
    • 12.5 Cataract Surgery Company Share (2006-2007)
  • 13 Refractive Surgery in Canada
    • 13.1 Refractive Surgery Revenues (2000-2012)
    • 13.2 Refractive Surgery Volume (2000-2012)
    • 13.3 Refractive Surgery Average Price (2000-2012)
    • 13.4 Refractive Surgery Distribution Share (2006-2007)
    • 13.5 Refractive Surgery Company Share (2006-2007)
  • 14 Alcon, Inc. Company Profile
    • 14.1 Company Overview
    • 14.2 Value Chain Analysis
      • 14.2.1 Manufacturing
      • 14.2.2 Product Development
      • 14.2.3 Sales and Marketing
    • 14.3 Alcon, Inc. Pipeline Products
      • 14.3.1 Alcon, Inc. Pipeline Products by Equipment Type
      • 14.3.2 Alcon, Inc. Pipeline Products by Development Stage
      • 14.3.3 Alcon, Inc. Pipeline Products by Therapy Area
      • 14.3.4 Alcon, Inc. Pipeline Products by Clinical Trials
  • 15 Bausch & Lomb Incorporated Company Profile
    • 15.1 Company Overview
    • 15.2 Value Chain Analysis
      • 15.2.1 Manufacturing
      • 15.2.2 Product Development
      • 15.2.3 Sales and Marketing
    • 15.3 Bausch & Lomb Incorporated Pipeline Products
      • 15.3.1 Bausch & Lomb Incorporated Pipeline Products by Equipment Type
      • 15.3.2 Bausch & Lomb Incorporated Pipeline Products by Development Stage
      • 15.3.3 Bausch & Lomb Incorporated Pipeline Products by Therapy Area
      • 15.3.4 Bausch & Lomb Incorporated Pipeline Products by Clinical Trials
      • 15.3.5 Bausch & Lomb Incorporated Pipeline Products by News Summary
  • 16 Carl Zeiss AG Company Profile
    • 16.1 Company Overview
    • 16.2 Value Chain Analysis
      • 16.2.1 Manufacturing
      • 16.2.2 Product Development
      • 16.2.3 Sales and Marketing
  • 17 Essilor International Company Profile
    • 17.1 Company Overview
    • 17.2 Value Chain Analysis
      • 17.2.1 Manufacturing
      • 17.2.2 Product Development
      • 17.2.3 Sales and Marketing
  • 18 Johnson & Johnson Vision Care, Inc. Company Profile
    • 18.1 Company Overview
  • 19 Financial Deals Landscape
    • 19.1 Acquisition
      • 19.1.1 OPKO Health Acquires Ophthalmic Technologies
      • 19.1.2 eXegenics acquire Ophthalmic Technologies
    • 19.2 Venture Financing
      • 19.2.1 Novadaq Technologies Raises $9 Million In Venture Financing
    • 19.3 IPO
      • 19.3.1 Occulogix Completes Private Placement Of Common Stock For $10 Million
      • 19.3.2 Occulogix Completes IPO
    • 19.4 Debt Offerings
      • 19.4.1 Angiotech Pharmaceuticals Closes $325 Million Private Placement
      • 19.4.2 Angiotech Pharmaceuticals Announces Public Offering Of $84.19 Million
      • 19.4.3 Angiotech Pharmaceuticals Announces Public Offering Of $77.7 Million
      • 19.4.4 Angiotech Enters Into A Licensing Agreement With Symphony Medical
      • 19.4.5 Boston Scientific Enters Into Licensing Agreement With Angiotech Pharmaceuticals
  • 20 Appendix
    • 20.1 Global Markets Direct Research Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panels
    • 20.8 Currency Conversion
    • 20.9 Contact Us
    • 20.10 Disclaimer
    • 1.1 List of Tables
    • Table 1: Number of Physicians by Province in Canada, 2001 and 2005
    • Table 2: Hospital Wards by Specialty in Canada, 2003-2007
    • Table 3: Doctors by Specialty in Canada, 2003-2007
    • Table 4: Medical Equipment Classification in Canada, 2007
    • Table 5: Medical Equipment Licensing Fee in Canada, 2007
    • Table 6: Medical Equipment License Processing Duration in Canada, 2007
    • Table 7: Canada, Medical Equipment Market Comparison
    • Table 8: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012
    • Table 9: Ophthalmic Devices, Canada, Category Revenues ($ mn), 2000-2012
    • Table 10: Ophthalmic Devices Market, Canada, Portfolio Analysis
    • Table 11: Ophthalmic Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007
    • Table 12: Ophthalmic Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 13: Ophthalmic Devices, United States, Category Volume (Units), 2000-2012
    • Table 14: Ophthalmic Devices, United States, Category Volume (Units), Historic, 2000-2007
    • Table 15: Ophthalmic Devices, United States, Category Volume (Units), Forecast, 2007-2012
    • Table 16: Ophthalmic Devices, Canada, Overall Company Share by Revenue, 2006-2007
    • Table 17: Vision Care, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 18: Vision Care, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 19: Vision Care, United States, Volume (Units) by Segment, Historic, 2000-2007
    • Table 20: Vision Care, United States, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 21: Vision Care, Canada, Average Price ($), Historic, 2000-2007
    • Table 22: Vision Care, Canada, Average Price ($), Forecast, 2007-20012
    • Table 23: Vision Care, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 24: Vision Care, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 25: Cataract Surgery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 26: Cataract Surgery, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 27: Cataract Surgery, Canada, Volume (Units) by Segment, Historic, 2000-2007
    • Table 28: Cataract Surgery, Canada, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 29: Cataract Surgery, Canada, Average Price ($), Historic, 2000-2007
    • Table 30: Cataract Surgery, Canada, Average Price ($), Forecast, 2007-2012
    • Table 31: Cataract Surgery, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 32: Cataract Surgery, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 33: Refractive Surgery, Canada, Revenues ($ mn), Historic, 2000-2007
    • Table 34: Refractive Surgery, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Table 35: Refractive Surgery, Canada, Volume (Units), Historic, 2000-2007
    • Table 36: Refractive Surgery, Canada, Volume (Units), Forecast, 2007-2012
    • Table 37: Refractive Surgery, Canada, Average Price ($), Historic, 2000-2007
    • Table 38: Refractive Surgery, Canada, Average Price ($), Forecast, 2007-2012
    • Table 39: Refractive Surgery, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 40: Refractive Surgery, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 41: Alcon, Inc. Pipeline Products by Equipment Type
    • Table 42: Alcon, Inc. Pipeline Products By Development Stage
    • Table 43: Alcon, Inc. Pipeline Products By Therapy Area
    • Table 44: Alcon, Inc. Pipeline Products By Clinical Trials
    • Table 45: Bausch & Lomb Incorporated Pipeline Products by Equipment Type
    • Table 46: Bausch & Lomb Incorporated Pipeline Products By Development Stage
    • Table 47: Bausch & Lomb Incorporated Pipeline Products By Therapy Area
    • Table 48: Bausch & Lomb Incorporated Pipeline Products By Clinical Trials
    • Table 49: Bausch & Lomb Incorporated Pipeline Products By News Summaries
    • Table 50: Currency Conversion from USD to Local Currency at 2007 Constant Rate
    • 1.2 List of Figures
    • Figure 1: Healthcare Financing in Canada, 2004
    • Figure 2: Healthcare Expenditure in Canada, 2000 - 2006
    • Figure 3: Canada, Medical Equipment Market Comparison,2007
    • Figure 4: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012
    • Figure 5: Ophthalmic Devices Market, Country Comparison
    • Figure 6: Ophthalmic Devices, Canada, Category Revenues ($ mn), 2000-2012
    • Figure 7: Ophthalmic Devices Market, Canada, Portfolio Analysis
    • Figure 8: Ophthalmic Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 9: Ophthalmic Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 10: Ophthalmic Devices, Canada, Overall Company Share (%), 2007
    • Figure 11: Vision Care, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 12: Vision Care, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 13: Vision Care, Canada, Company Share (%), 2007
    • Figure 14: Cataract Surgery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 15: Cataract Surgery, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 16: Cataract Surgery, Canada, Company Share (%), 2007
    • Figure 17: Refractive Surgery, Canada, Revenues ($ mn), Historic, 2000-2007
    • Figure 18: Refractive Surgery, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Figure 19: Refractive Surgery, Canada, Volume (Units), Historic, 2000-2007
    • Figure 20: Refractive Surgery, Canada, Volume (Units), Forecast, 2007-2012
    • Figure 21: Refractive Surgery, Canada, Company Share (%), 2007
    • Figure 22: Alcon, Inc., Value Chain Analysis
    • Figure 23: Bausch & Lomb Incorporated, Value Chain Analysis
    • Figure 24: Carl Zeiss AG, Value Chain Analysis
    • Figure 25: Essilor International, Value Chain Analysis
    • Figure 26: Global Markets Direct Methodology